Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities
Ovarian cancer (OC) is the most lethal gynecologic malignancy worldwide. Due to the lack of effective screening and early detection strategies, many patients with OC are diagnosed with advanced disease, where treatment is rarely curative. Moreover, OC is characterized by high intratumor heterogeneit...
Saved in:
Main Authors: | Elena Trevisi (Author), Cristiana Sessa (Author), Ilaria Colombo (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches
by: Benjamin Ribba, et al.
Published: (2023) -
Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017) -
Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
by: Fang Yang, et al.
Published: (2021) -
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients
by: Maria Kfoury, et al.
Published: (2023) -
Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies
Published: (2020)